
Organometallics p. 989 - 992 (1992)
Update date:2022-07-30
Topics:
Omori, Hideki
Suzuki, Hiroharu
Kakigano, Takeaki
Moro-oka, Yoshihiko
The reaction of a dinuclear tetrahydrido-ruthenium complex (η5-C5Me5)Ru(μ-H) 4Ru(η5-C5Me5) (1) with 2 equiv of diphenylacetylene results in the formation of the dinuclear ruthenium dihydride complex (η5-C5Me5)Ru(7μ-H) 2(μ-PhCCPh)Ru(η5-C5Me5) (2), which contains a perpendicularly bridging diphenylacetylene ligand. The complex crystallizes in the triclinic system, in space group P1, with a = 10.284 (4) A?, b = 15.871 (4) A?, c = 10.286 (3) A?, α = 98.47 (3)°, β = 110.92 (2)°, α = 98.22 (3)°, V = 1515.8 (9) A?3, and Z = 2. Anisotropic refinement of all atoms except hydrogen atoms converged to the residuals R = 0.0569 and Rw = 0.0539 for 6177 reflections.
Contact:+86-10-83993285
Address:Rm.1708, Haobai Tower, Building 6, No.50, North Road, West Third Ring, Haidian District, Beijing, China
website:http://www.apeptides.com/en/
Contact:+86-21-60871011
Address:No. 80 Chuanshan Shuyuan Steet,Pudong,Shanghai
shijiazhuang shuanglian chemical industry co.,ltd
Contact:0311-82190302
Address:Luquan Intersection , Shijiazhuang--Taiyuan Expressway,Shijiazhuang City
Contact:+86 755 26588093
Address:No.9 Linkong West Street, Hengdian Street, Huangpi District, Wuhan City, China.
Beijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Doi:10.1021/jo00030a024
(1992)Doi:10.1055/s-1991-26619
(1991)Doi:10.1139/v91-303
(1991)Doi:10.1515/chempap-2016-0078
(2016)Doi:10.1021/acs.orglett.9b01992
(2019)Doi:10.3906/kim-1106-54
(2012)